Embolization Coils Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Detachable Coil and Pushable Coil) By Material (Platinum, Platinum & Hydrogel and Platinum Tungsten Alloy) By Application (Neurology, Cardiology, Urology, Oncology and Peripheral Vascular Disease) By End-user (Cardiac Center, Hospitals and Ambulatory Center), and Region

Embolization Coils Market size was valued at US$ 1,829.3 million in 2023 and poised to grow at 4.9% CAGR from (2024-2030).  Embolization Coils are medical devices used in performing a procedure called coil embolization, which is a minimally invasive treatment designed to block blood flow to an area of the body. These coils are usually utilized in treating aneurysms, especially in the brain and for hemorrhage control in other parts of the body by initiating blood clotting at the area under consideration. These coils are made of materials such as platinum, which can be imaged by X-rays, and are inserted using a catheter into the blood vessel that has to be occluded. When the coil is in situ, it will create clotting, thereby occluding the aneurysm or stopping the bleeding. It is anticipated that the growing cases of cerebral aneurysms and other vascular diseases will majorly boost the embolization coils market.

As all of these are potentially life-threatening diseases and their treatment is quite essential to avert serious complications such as strokes, demand for embolization coils has been increasing. Moreover, an aging global population, which is more susceptible to aneurysms and vascular diseases, is driving the demand for embolization coils.   Although embolization is considered a minimally invasive procedure, risks of complications, such as coil migration or incomplete occlusion, might subsequently deter its use in some. Also, the cost associated with embolization procedures can be prohibitive, particularly in developing countries, limiting market growth. Whereas, ongoing research and development in coil materials and delivery systems present opportunities for market growth. Newer coils with better flexibility, visibility, and clotting capabilities are continually being developed. Probably one of the most recent developments in embolization coils was in 2023 with a next-generation hydrogel-coated coil launch by one of the world's biggest medical device manufacturers.

Embolization Coils Market Key Developments:

• In 2023: Terumo Medical Corporation received FDA approval for its Azur Vascular Plug, a device used in conjunction with embolization coils for peripheral vascular embolization.
• In 2022: MicroVention, Inc., a subsidiary of Terumo, received FDA clearance for its SOFIA Plus 6F Guide Catheter. Although this is not a coil, it is directly related to embolization procedures as it facilitates the delivery of embolization coils and other neurovascular devices.
• In 2021: Penumbra, a prominent medical device company, received FDA approval for its SMART Coil System.